Detalhe da pesquisa
1.
Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial.
Antimicrob Agents Chemother
; 67(1): e0112322, 2023 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36507677
2.
Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects.
Antimicrob Agents Chemother
; 66(1): e0143621, 2022 01 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34694872
3.
Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors.
Bioorg Med Chem Lett
; 24(23): 5473-7, 2014 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25455487
4.
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
Bioorg Med Chem Lett
; 23(1): 153-7, 2013 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23206860
5.
A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.
Bioorg Med Chem Lett
; 22(7): 2522-6, 2012 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22374216
6.
The Assessment of Brain Volume Differences in Idiopathic Central Precocious Puberty Girls; Comparison of Age-Matched Girls and Normal Puberty Girls.
Children (Basel)
; 8(9)2021 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34572229
7.
GM-CSF and IL-4 produced by NKT cells inversely regulate IL-1ß production by macrophages.
Immunol Lett
; 182: 50-56, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28063891